Stock-based Compensation - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				9 Months Ended	12 Months Ended
	Sep. 30, 2021	[1]	Mar. 31, 2021	[1]	Sep. 30, 2022	Dec. 31, 2021
Number of Shares Underlying Outstanding Options
Number of shares underlying outstanding options, beginning balance (in shares)					24,129,096
Number of shares underlying outstanding options, options exercised (in shares)	(186,165)		(727,114)		(1,753,708)
Number of shares underlying outstanding options, options cancelled (in shares)					(857,212)
Number of shares underlying outstanding options, ending balance (in shares)					21,518,176	24,129,096
Number of shares underlying outstanding options, vested and expected to vest (in shares)					21,518,176
Number of shares underlying outstanding options, exercisable (in shares)					11,545,615
Weighted- Average Exercise Price per Share
Weighted average exercise price, beginning balance (in dollars per share)					$ 1.01
Weighted average exercise price, options exercised (in dollars per share)					0.20
Weighted average exercise price, options cancelled (in dollars per share)					2.85
Weighted average exercise price, ending balance (in dollars per share)					1.01	$ 1.01
Weighted average exercise price, options vested and expected to vest (in dollars per share)					1.01
Weighted average exercise price, options exercisable (in dollars per share)					$ 0.89
Weighted- Average Remaining Contractual Term (in years)
Stock options outstanding, weighted average remaining contractual term					7 years 11 months 1 day	8 years 7 months 6 days
Stock options vested and expected to vest, weighted average remaining contractual term					7 years 11 months 1 day
Stock options exercisable, weighted average remaining contractual term					7 years 10 months 9 days
Aggregate Intrinsic Value
Stock options outstanding, aggregate intrinsic value, beginning balance					$ 100,992
Stock options outstanding, aggregate intrinsic value, ending balance					9,866	$ 100,992
Stock options vested and expected to vest, aggregate intrinsic value					9,866
Stock options exercisable, aggregate intrinsic value					$ 5,669

[1] (1) The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1), have been retroactively restated as shares reflecting the exchange ratio of approximately 0.703 established in the Merger as described in Note 1.